1. Home
  2. SVCO vs VXRT Comparison

SVCO vs VXRT Comparison

Compare SVCO & VXRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SVCO
  • VXRT
  • Stock Information
  • Founded
  • SVCO 1984
  • VXRT N/A
  • Country
  • SVCO United States
  • VXRT United States
  • Employees
  • SVCO N/A
  • VXRT N/A
  • Industry
  • SVCO
  • VXRT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • SVCO
  • VXRT Health Care
  • Exchange
  • SVCO NYSE
  • VXRT Nasdaq
  • Market Cap
  • SVCO 140.5M
  • VXRT 119.0M
  • IPO Year
  • SVCO 2024
  • VXRT N/A
  • Fundamental
  • Price
  • SVCO $5.00
  • VXRT $0.43
  • Analyst Decision
  • SVCO Strong Buy
  • VXRT Strong Buy
  • Analyst Count
  • SVCO 5
  • VXRT 2
  • Target Price
  • SVCO $17.00
  • VXRT $3.00
  • AVG Volume (30 Days)
  • SVCO 96.8K
  • VXRT 9.5M
  • Earning Date
  • SVCO 08-06-2025
  • VXRT 08-07-2025
  • Dividend Yield
  • SVCO N/A
  • VXRT N/A
  • EPS Growth
  • SVCO N/A
  • VXRT N/A
  • EPS
  • SVCO N/A
  • VXRT N/A
  • Revenue
  • SVCO $57,883,000.00
  • VXRT $47,395,000.00
  • Revenue This Year
  • SVCO $14.25
  • VXRT N/A
  • Revenue Next Year
  • SVCO $15.85
  • VXRT N/A
  • P/E Ratio
  • SVCO N/A
  • VXRT N/A
  • Revenue Growth
  • SVCO 3.65
  • VXRT 433.43
  • 52 Week Low
  • SVCO $3.55
  • VXRT $0.29
  • 52 Week High
  • SVCO $20.69
  • VXRT $1.07
  • Technical
  • Relative Strength Index (RSI)
  • SVCO N/A
  • VXRT 41.65
  • Support Level
  • SVCO N/A
  • VXRT $0.54
  • Resistance Level
  • SVCO N/A
  • VXRT $0.60
  • Average True Range (ATR)
  • SVCO 0.00
  • VXRT 0.08
  • MACD
  • SVCO 0.00
  • VXRT -0.02
  • Stochastic Oscillator
  • SVCO 0.00
  • VXRT 3.61

About SVCO SILVACO GROUP INC

Silvaco Group Inc is a provider of technology computer aided design (TCAD) software, electronic data automation (EDA) software and semiconductor intellectual property (SIP). TCAD, EDA and SIP solutions enable semiconductor and photonics companies to increase productivity, accelerate their products' time-to-market and reduce their development and manufacturing costs. It is developing the technology behind the chip and providing solutions that span from atoms to systems, starting with providing software for the atomic level simulation of semiconductor and photonics material for devices, to providing software and SIP for the design and analysis of circuits and system level solutions.

About VXRT Vaxart Inc

Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.

Share on Social Networks: